Goodwin Biotechnology, Inc. (GBI), based near Fort Lauderdale, Florida, is a fully integrated, customer-focused cGMP Contract Manufacturing Organization (CMO) of Biosimilar and innovative monoclonal antibodies, recombinant proteins, vaccines, Antibody Drug Conjugates (ADCs), and other bioconjugates.
Service Offerings:
Cell Line Development with Strategic Partner
GMP Cell Banking
Analytical Method Development
Antibody Characterization Services